- Home
- HBANL vs XGN Comparison
HBANL vs XGN Comparison
Compare HBANL & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HBANL
Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Current Price
Company Overview
Basic Information| Metric | HBANL | XGN |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | 20424 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 64.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | HBANL | XGN |
|---|---|---|
| Price | $24.84 | $3.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 27.0K | ★ 243.0K |
| Earning Date | N/A | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.06 |
| Revenue Next Year | N/A | $12.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.31 | $2.59 |
| 52 Week High | $26.42 | $12.23 |
Technical Indicators
Market Signals| Indicator | HBANL | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 48.30 |
| Support Level | $24.55 | $2.59 |
| Resistance Level | $25.62 | $3.79 |
| Average True Range (ATR) | 0.29 | 0.21 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 48.57 | 75.00 |
Price Performance
Historical ComparisonAbout HBANL Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with over $275 billion in assets. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.